US Patent Law in Life Sciences: Description and Enablement Requirement Developments

This presentation will be conducted in Chinese, with bilingual slides displayed in both English and Chinese.

Topics will include:

• The newest developments in the written description of US patent law, seen in Juno Therapeutics, Inc. v. Kite Pharma, Inc.
• The newest developments in the enablement of US patent law, seen in Amgen Inc. vs. Sanofi
• Intertwining written descriptions and enablement
• How to draft claims of life science patent applications to meet both written descriptions and enablement